Getty images / skynesher

CBD in 2022: A year in review

By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

© Getty Images

Parliamentary group divided on proposals for new CBD approval system

By Nicola Gordon-Seymour

Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.

© Getty Images

Study: Many CBD products would trigger doping bans

By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

© Getty Images

UK’s FSA unveils list of permitted CBD products

By Kavitha Sivasubramaniam

The UK’s Food Standards Agency (FSA) has released a list of cannabinoid (CBD) products which can be sold to consumers, becoming the first country globally to regulate the market for orally consumed, safe legal cannabis extracts.

A growing number of firms are using genetically engineered yeast to biosynthesize cannabinoids by effectively reverse engineering how Cannabis sativa plants make these molecules (picture: Demetrix)

Demetrix begins demo scale production of rare cannabinoid CBG

By Elaine Watson

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...

Getty Images

Weighing the risks of CBD in sports nutrition

By Danielle Masterson

As cannabis legalization spreads across the country, professional sports leagues are updating their policies, while some players update their portfolios.

NutraCast Podcast: Patrick McCarthy on CBD research and regulation

NutraCast Podcast: Patrick McCarthy on CBD research and regulation

By Danielle Masterson

In recent months the FDA has been trying to figure out how to get the CBD market under control, with the focus on safety. Patrick McCarthy, CEO of Validcare, a cannabis sector-focused health and wellness research company, said the FDA is not going to...


Follow us


View more


Featured Suppliers